JP2007529495A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007529495A5 JP2007529495A5 JP2007503427A JP2007503427A JP2007529495A5 JP 2007529495 A5 JP2007529495 A5 JP 2007529495A5 JP 2007503427 A JP2007503427 A JP 2007503427A JP 2007503427 A JP2007503427 A JP 2007503427A JP 2007529495 A5 JP2007529495 A5 JP 2007529495A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- benzyl
- piperazin
- phenyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55380804P | 2004-03-17 | 2004-03-17 | |
| US60/553,808 | 2004-03-17 | ||
| PCT/IB2005/000583 WO2005090300A1 (en) | 2004-03-17 | 2005-03-07 | Novel benzyl(idene)-lactam derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007529495A JP2007529495A (ja) | 2007-10-25 |
| JP2007529495A5 true JP2007529495A5 (https=) | 2008-04-24 |
| JP4880583B2 JP4880583B2 (ja) | 2012-02-22 |
Family
ID=34960867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007503427A Expired - Fee Related JP4880583B2 (ja) | 2004-03-17 | 2005-03-07 | 新規なベンジル（ベンジリデン）−ラクタム誘導体 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7479559B2 (https=) |
| EP (1) | EP1727794B1 (https=) |
| JP (1) | JP4880583B2 (https=) |
| KR (1) | KR20060124770A (https=) |
| CN (1) | CN1934081A (https=) |
| AP (1) | AP2006003726A0 (https=) |
| AR (1) | AR050403A1 (https=) |
| AT (1) | ATE533745T1 (https=) |
| AU (1) | AU2005223481A1 (https=) |
| BR (1) | BRPI0508825A (https=) |
| CA (1) | CA2559530C (https=) |
| CR (1) | CR8618A (https=) |
| DO (1) | DOP2005000035A (https=) |
| EA (1) | EA200601461A1 (https=) |
| EC (1) | ECSP066853A (https=) |
| ES (1) | ES2374629T3 (https=) |
| GT (1) | GT200500051A (https=) |
| IL (1) | IL178105A0 (https=) |
| MA (1) | MA28474B1 (https=) |
| NL (1) | NL1028558C2 (https=) |
| NO (1) | NO20063602L (https=) |
| PA (1) | PA8626501A1 (https=) |
| PE (1) | PE20051153A1 (https=) |
| SV (1) | SV2005002051A (https=) |
| TN (1) | TNSN06287A1 (https=) |
| TW (1) | TW200604165A (https=) |
| UY (1) | UY28811A1 (https=) |
| WO (1) | WO2005090300A1 (https=) |
| ZA (1) | ZA200607133B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1836164B1 (en) | 2005-01-13 | 2011-08-24 | GE Healthcare Limited | 11c-labeled benzyl-lactam compounds and their use as imaging agents |
| CA2612268A1 (en) * | 2005-06-17 | 2006-12-28 | Pfizer Products Inc. | Metabolites of 1-[6-(1-ethyl-1-hydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one as seratonin receptor antagonists |
| WO2007026219A2 (en) * | 2005-08-31 | 2007-03-08 | Pfizer Products Inc. | Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions |
| WO2008068614A2 (en) * | 2006-12-06 | 2008-06-12 | Pfizer Products Inc. | Stereoselective synthesis of 1-[6-ethyl-1,2-dihydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one |
| FR2948660B1 (fr) * | 2009-07-30 | 2011-08-19 | Oroxcell | Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| EP2338873A1 (en) | 2009-12-22 | 2011-06-29 | Gmeiner, Peter | New aminotetraline derivatives |
| AU2010336027A1 (en) * | 2009-12-23 | 2012-07-19 | Auckland Uniservices Limited | Compounds, preparations and uses thereof |
| EP2884978B1 (en) | 2012-08-16 | 2019-07-17 | The Scripps Research Institute | Novel kappa opioid ligands |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| MX2016008842A (es) | 2014-01-20 | 2016-11-08 | Hoffmann La Roche | Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos. |
| ES2730112T3 (es) | 2015-03-09 | 2019-11-08 | Bristol Myers Squibb Co | Lactamas como inhibidores de ROCK |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
| CN119219603A (zh) * | 2023-06-28 | 2024-12-31 | 科辉智药(深圳)新药研究中心有限公司 | Sarm1酶活性抑制剂及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58189163A (ja) * | 1982-04-02 | 1983-11-04 | Takeda Chem Ind Ltd | 縮合ピロリノン誘導体 |
| IL106142A (en) | 1992-06-29 | 1997-03-18 | Merck & Co Inc | Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them |
| ATE201403T1 (de) | 1993-03-16 | 2001-06-15 | Pfizer | Naphtalinderivate |
| JP3786983B2 (ja) * | 1994-01-27 | 2006-06-21 | シエーリング アクチエンゲゼルシャフト | ピロリジノン誘導体 |
| GB9410512D0 (en) | 1994-05-25 | 1994-07-13 | Smithkline Beecham Plc | Novel treatment |
| CA2193388C (en) | 1994-06-29 | 2005-07-26 | Bertrand L. Chenard | Aryl and heteroaryl alkoxynaphthalene derivatives |
| NZ325914A (en) * | 1996-03-29 | 1999-09-29 | Pfizer | Benzyl(idene)-lactam derivatives and salts thereof, their preparation and their use as selective (ant)agonists of 5-ht1a and/or 5-ht1d receptors and thus are effective as psychotherapeutic agents |
| UA56185C2 (uk) * | 1996-09-30 | 2003-05-15 | Пфайзер Інк. | Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування |
| US6423708B1 (en) * | 1996-09-30 | 2002-07-23 | Pfizer Inc | Aralkyl and aralkylidene heterocyclic lactams and imides |
| DE10002509A1 (de) | 2000-01-21 | 2001-07-26 | Gruenenthal Gmbh | Substituierte Glutarimide |
| US20020049211A1 (en) * | 2000-09-06 | 2002-04-25 | Sobolov-Jaynes Susan Beth | Combination treatment for depression and anxiety |
| TWI263640B (en) * | 2001-12-19 | 2006-10-11 | Bristol Myers Squibb Co | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
-
2005
- 2005-03-07 AT AT05708687T patent/ATE533745T1/de active
- 2005-03-07 EA EA200601461A patent/EA200601461A1/ru unknown
- 2005-03-07 CN CNA2005800085634A patent/CN1934081A/zh active Pending
- 2005-03-07 AU AU2005223481A patent/AU2005223481A1/en not_active Abandoned
- 2005-03-07 JP JP2007503427A patent/JP4880583B2/ja not_active Expired - Fee Related
- 2005-03-07 ES ES05708687T patent/ES2374629T3/es not_active Expired - Lifetime
- 2005-03-07 AP AP2006003726A patent/AP2006003726A0/xx unknown
- 2005-03-07 CA CA2559530A patent/CA2559530C/en not_active Expired - Fee Related
- 2005-03-07 BR BRPI0508825-9A patent/BRPI0508825A/pt not_active IP Right Cessation
- 2005-03-07 WO PCT/IB2005/000583 patent/WO2005090300A1/en not_active Ceased
- 2005-03-07 KR KR1020067019078A patent/KR20060124770A/ko not_active Ceased
- 2005-03-07 EP EP05708687A patent/EP1727794B1/en not_active Expired - Lifetime
- 2005-03-10 DO DO2005000035A patent/DOP2005000035A/es unknown
- 2005-03-15 PE PE2005000296A patent/PE20051153A1/es not_active Application Discontinuation
- 2005-03-15 UY UY28811A patent/UY28811A1/es not_active Application Discontinuation
- 2005-03-15 TW TW094107893A patent/TW200604165A/zh unknown
- 2005-03-15 GT GT200500051A patent/GT200500051A/es unknown
- 2005-03-16 NL NL1028558A patent/NL1028558C2/nl not_active IP Right Cessation
- 2005-03-16 AR ARP050101025A patent/AR050403A1/es unknown
- 2005-03-16 SV SV2005002051A patent/SV2005002051A/es not_active Application Discontinuation
- 2005-03-17 US US11/083,188 patent/US7479559B2/en not_active Expired - Fee Related
- 2005-03-17 PA PA20058626501A patent/PA8626501A1/es unknown
-
2006
- 2006-08-09 NO NO20063602A patent/NO20063602L/no not_active Application Discontinuation
- 2006-08-25 ZA ZA200607133A patent/ZA200607133B/en unknown
- 2006-09-13 CR CR8618A patent/CR8618A/es not_active Application Discontinuation
- 2006-09-14 IL IL178105A patent/IL178105A0/en unknown
- 2006-09-15 TN TNP2006000287A patent/TNSN06287A1/fr unknown
- 2006-09-15 EC EC2006006853A patent/ECSP066853A/es unknown
- 2006-09-15 MA MA29327A patent/MA28474B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100524159B1 (ko) | 모노아민 재흡수 억제제로서 유용한 비아릴 에테르 유도체 | |
| JP2007529495A5 (https=) | ||
| JP7453916B2 (ja) | Ｏ－糖タンパク質－２－アセトアミド－２－デオキシ－３－ｄ－グリコピラノシダーゼ阻害剤 | |
| JP7130873B2 (ja) | バニン阻害剤としてのヘテロ芳香族化合物 | |
| AU2018287787A1 (en) | Dihydro-pyrrolo-pyridine derivatives | |
| KR101886945B1 (ko) | 감마-세크레타제 조절제로서의 크로멘 및 1,1a,2,7b-테트라히드로시클로프로파[c]크로멘 피리도피라진디온 | |
| PT1353917E (pt) | Novo processo de síntese de fenilamida do ácido 5-(4-fluorofenil)-1-[2-((2r,4r)-4-hidroxi-6-oxo-tetra-hidro-piran-2-il)-etil]-2-isopro-pil-4-fenil-1h-pirrole-3-carboxílico | |
| JP2008526966A (ja) | β−セクレターゼの阻害のためのアミノ−イミダゾロン | |
| EA026668B1 (ru) | Новые бициклические пиридиноны | |
| EA031614B1 (ru) | Трициклические атропоизомерные соединения | |
| JP6496246B2 (ja) | アルドステロンシンターゼインヒビター関連用途としてのインドリン化合物 | |
| JP4880583B2 (ja) | 新規なベンジル（ベンジリデン）−ラクタム誘導体 | |
| Firth et al. | Revisiting the sparteine surrogate: development of a resolution route to the (−)-sparteine surrogate | |
| KR101514505B1 (ko) | Ｎｋ3 수용체 길항제로서 피롤리딘 유도체 | |
| EP2590963B1 (en) | (3-methylpyrrolidin-3-yl)methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists | |
| CN105102454A (zh) | 作为cetp抑制剂的新型噁唑烷酮衍生物、其制备方法和包含其的药物组合物 | |
| JP2021505555A (ja) | ベンゼン縮合複素環化合物およびその使用 | |
| HUP0003958A2 (hu) | Eljárás 4-aril-piperidinek előállítására és az eljárásban alkalmazott intermedierek | |
| DE69210675T2 (de) | 3-Aryloxazolidinonderivate, Verfahren zu ihrer Herstellung und ihre Anwendung in der Heilkunde | |
| AU2004289616B2 (en) | Morpholine derivatives as norepinephrine reuptake inhibitors | |
| JP2014508125A (ja) | ジアステレオ異性有機化合物の製造方法 | |
| HK1242315A1 (en) | Novel cyclopropabenzofuranyl pyridopyrazinediones | |
| HK40027664A (en) | Dihydro-pyrrolo-pyridine derivatives | |
| HK1231481B (zh) | 作为γ-分泌酶调节剂的色烯和1，1A，2，7B-四氢环丙烷并[C]色烯吡啶并吡嗪二酮 |